• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

壳聚糖作为口服和局部用卡维地洛给药系统的重要辅料。

Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems.

作者信息

Sip Szymon, Paczkowska-Walendowska Magdalena, Rosiak Natalia, Miklaszewski Andrzej, Grabańska-Martyńska Katarzyna, Samarzewska Karolina, Cielecka-Piontek Judyta

机构信息

Department of Pharmacognosy, Poznan University of Medical Sciences, 4 Swiecickiego Street, 60-781 Poznan, Poland.

Institute of Materials Science and Engineering, Poznan University of Technology, Jana Pawła II 24, 61-138 Poznan, Poland.

出版信息

Pharmaceuticals (Basel). 2021 Jul 23;14(8):712. doi: 10.3390/ph14080712.

DOI:10.3390/ph14080712
PMID:34451809
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8401298/
Abstract

Chitosan is a valued excipient due to its biocompatibility properties and increasing solubility of poorly water-soluble drugs. The research presented in this paper concerns the preparation of binary combinations of chitosan (deacetylated chitin) with carvedilol (beta-blocker) to develop a formulation with a modified carvedilol release profile. As part of the research, six physical mixtures of chitosan with carvedilol were obtained and identified by spectral (PXRD, FT-IR, and Raman), thermal (DSC), and microscopic (SEM) methods. The next stage of the research estimated the profile changes and the dissolution rate for carvedilol in the obtained drug delivery systems; the reference sample was pure carvedilol. The studies were conducted at pH = 1.2 and 6.8, simulating the gastrointestinal tract conditions. Quantitative changes of carvedilol were determined using the developed isocratic UHPLC-DAD method. Established apparent permeability coefficients proved the changes in carvedilol's permeability after introducing a drug delivery system through membranes simulating the gastrointestinal tract and skin walls. A bioadhesive potential of carvedilol-chitosan systems was confirmed using the in vitro model. The conducted research and the obtained results indicate a significant potential of using chitosan as an excipient in modern oral or epidermal drug delivery systems of carvedilol.

摘要

壳聚糖因其生物相容性以及能提高难溶性药物的溶解度,是一种很有价值的辅料。本文所呈现的研究涉及壳聚糖(脱乙酰甲壳素)与卡维地洛(β受体阻滞剂)二元组合的制备,以开发一种具有改良卡维地洛释放曲线的制剂。作为研究的一部分,制备了壳聚糖与卡维地洛的六种物理混合物,并通过光谱(粉末X射线衍射、傅里叶变换红外光谱和拉曼光谱)、热分析(差示扫描量热法)和显微镜(扫描电子显微镜)方法进行了鉴定。研究的下一阶段评估了卡维地洛在所获得的药物递送系统中的曲线变化和溶解速率;参考样品为纯卡维地洛。研究在pH = 1.2和6.8条件下进行,模拟胃肠道环境。使用所开发的等度超高效液相色谱 - 二极管阵列检测法测定了卡维地洛的定量变化。确定的表观渗透系数证明了在通过模拟胃肠道和皮肤壁的膜引入药物递送系统后,卡维地洛的渗透性发生了变化。使用体外模型证实了卡维地洛 - 壳聚糖系统的生物黏附潜力。所进行的研究和获得的结果表明,壳聚糖在现代卡维地洛口服或表皮药物递送系统中作为辅料具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/b9f3273f438c/pharmaceuticals-14-00712-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/92a263302cd1/pharmaceuticals-14-00712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/016256f48506/pharmaceuticals-14-00712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/b85c65516374/pharmaceuticals-14-00712-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/9039be3064f1/pharmaceuticals-14-00712-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/14ac9959659f/pharmaceuticals-14-00712-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/96cdf2da86f6/pharmaceuticals-14-00712-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/0cd5985ecb30/pharmaceuticals-14-00712-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/d3d22f2c7084/pharmaceuticals-14-00712-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/b9f3273f438c/pharmaceuticals-14-00712-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/92a263302cd1/pharmaceuticals-14-00712-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/016256f48506/pharmaceuticals-14-00712-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/b85c65516374/pharmaceuticals-14-00712-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/9039be3064f1/pharmaceuticals-14-00712-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/14ac9959659f/pharmaceuticals-14-00712-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/96cdf2da86f6/pharmaceuticals-14-00712-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/0cd5985ecb30/pharmaceuticals-14-00712-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/d3d22f2c7084/pharmaceuticals-14-00712-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a89/8401298/b9f3273f438c/pharmaceuticals-14-00712-g009.jpg

相似文献

1
Chitosan as Valuable Excipient for Oral and Topical Carvedilol Delivery Systems.壳聚糖作为口服和局部用卡维地洛给药系统的重要辅料。
Pharmaceuticals (Basel). 2021 Jul 23;14(8):712. doi: 10.3390/ph14080712.
2
Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: Optimization and pharmacokinetic study.壳聚糖纳米粒增强难溶性卡维地洛的口服生物利用度:优化及药代动力学研究。
Int J Biol Macromol. 2019 Aug 15;135:246-260. doi: 10.1016/j.ijbiomac.2019.05.162. Epub 2019 May 23.
3
Intestinal Absorption and Pharmacokinetic Investigations of Carvedilol Loaded Supersaturated Self-emulsifying Drug System.卡维地洛负荷型超饱和自乳化药物传递系统的肠吸收及药代动力学研究。
Pharm Nanotechnol. 2020;8(3):207-224. doi: 10.2174/2211738508666200517121637.
4
Chitosan and chitosan chlorhydrate based various approaches for enhancement of dissolution rate of carvedilol.壳聚糖和盐酸壳聚糖为基础的各种方法提高卡维地洛的溶出度。
Daru. 2012 Dec 13;20(1):93. doi: 10.1186/2008-2231-20-93.
5
Mucoadhesive buccal patches based on interpolymer complexes of chitosan-pectin for delivery of carvedilol.基于壳聚糖-果胶的聚合物复合体制备具有黏膜黏附性的卡维地洛颊黏膜贴片。
Saudi Pharm J. 2012 Jan;20(1):21-7. doi: 10.1016/j.jsps.2011.04.005. Epub 2011 Apr 30.
6
Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development.作为指导控释药物产品开发的关键因素的片段依赖性溶解度和渗透性。
Pharmaceutics. 2020 Mar 24;12(3):295. doi: 10.3390/pharmaceutics12030295.
7
Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.新型快速合成中空介孔硅纳米粒子(HMSNs)的方案及其作为改善难溶性 BCS Ⅱ类药物口服生物利用度的有效递送载体的应用。
Colloids Surf B Biointerfaces. 2019 Apr 1;176:185-193. doi: 10.1016/j.colsurfb.2019.01.004. Epub 2019 Jan 2.
8
Novel chitosan-functionalized spherical nanosilica matrix as an oral sustained drug delivery system for poorly water-soluble drug carvedilol.新型壳聚糖功能化球形纳米硅基作为口服缓控释给药系统用于难溶性药物卡维地洛。
ACS Appl Mater Interfaces. 2013 Jan;5(1):103-13. doi: 10.1021/am302246s. Epub 2012 Dec 24.
9
Transdermal delivery of carvedilol containing glycyrrhizin and chitosan as permeation enhancers: biochemical, biophysical, microscopic and pharmacodynamic evaluation.以甘草酸和壳聚糖作为渗透促进剂的卡维地洛经皮给药:生化、生物物理、微观及药效学评价
Drug Deliv. 2008 Sep;15(7):443-54. doi: 10.1080/10717540802327047.
10
Two types of core/shell fibers based on carboxymethyl chitosan and Sodium carboxymethyl cellulose with self-assembled liposome for buccal delivery of carvedilol across TR146 cell culture and porcine buccal mucosa.两种基于壳聚糖和羧甲基纤维素钠的核/壳纤维,具有自组装脂质体,用于通过 TR146 细胞培养和猪口腔黏膜进行卡维地洛的口腔给药。
Int J Biol Macromol. 2019 May 1;128:700-709. doi: 10.1016/j.ijbiomac.2019.01.143. Epub 2019 Jan 26.

引用本文的文献

1
Thermal Compatibility of New ACEI Derivatives with Popular Excipients Used to Produce Solid Pharmaceutical Formulations.新型血管紧张素转换酶抑制剂(ACEI)衍生物与用于制备固体药物制剂的常用辅料的热相容性
Pharmaceuticals (Basel). 2024 Oct 3;17(10):1323. doi: 10.3390/ph17101323.
2
Intranasal Delivery of Carvedilol- and Quercetin-Encapsulated Cationic Nanoliposomes for Cardiovascular Targeting: Formulation and and Studies.载药阳离子纳米脂质体经鼻腔给药靶向心血管系统用于治疗:配方和研究
ACS Appl Bio Mater. 2024 May 20;7(5):3061-3085. doi: 10.1021/acsabm.4c00102. Epub 2024 Apr 6.
3
Chitosan-Based Hydrogels for Controlled Delivery of Asiaticoside-Rich Extracts with Wound Healing Potential.

本文引用的文献

1
Combinations of Piperine with Hydroxypropyl-β-Cyclodextrin as a Multifunctional System.胡椒碱与羟丙基-β-环糊精的组合作为多功能系统。
Int J Mol Sci. 2021 Apr 18;22(8):4195. doi: 10.3390/ijms22084195.
2
Tedizolid-Cyclodextrin System as Delayed-Release Drug Delivery with Antibacterial Activity.替考拉宁-环糊精系统作为具有抗菌活性的迟释药物递送系统。
Int J Mol Sci. 2020 Dec 24;22(1):115. doi: 10.3390/ijms22010115.
3
Development of carvedilol-loaded lipid nanoparticles with compatible lipids and enhanced skin permeation in different skin models.
基于壳聚糖的水凝胶用于控制含积雪草苷的提取物的释放,以实现潜在的伤口愈合效果。
Int J Mol Sci. 2023 Dec 7;24(24):17229. doi: 10.3390/ijms242417229.
4
Cubosomal functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: Recent advances in synergistic strategies for maximizing control of high-risk type II diabetes.基于 Cubosome 的功能化嵌段共聚物平台用于同时递送利拉鲁肽和恩格列净:最大化控制高危 2 型糖尿病的协同策略的最新进展。
Drug Deliv Transl Res. 2024 Mar;14(3):678-695. doi: 10.1007/s13346-023-01423-7. Epub 2023 Oct 8.
5
Synthesis and Characterization of Carvedilol-Etched Halloysite Nanotubes Composites with Enhanced Drug Solubility and Dissolution Rate.载有卡维地洛的刻蚀埃洛石纳米管复合材料的合成与表征,其药物溶解度和溶出速率得到增强。
Molecules. 2023 Apr 12;28(8):3405. doi: 10.3390/molecules28083405.
6
Development of a Self-Assembled Hydrogels Based on Carboxymethyl Chitosan and Oxidized Hyaluronic Acid Containing Tanshinone Extract Nanocrystals for Enhanced Dissolution and Acne Treatment.基于羧甲基壳聚糖和含丹参酮提取物纳米晶体的氧化透明质酸的自组装水凝胶的研制,用于增强溶解和痤疮治疗
Pharmaceuticals (Basel). 2022 Dec 9;15(12):1534. doi: 10.3390/ph15121534.
7
Solubilization and Controlled Release Strategy of Poorly Water-Soluble Drugs.难溶性药物的增溶与控释策略
Pharmaceuticals (Basel). 2022 Nov 2;15(11):1353. doi: 10.3390/ph15111353.
8
Chitosan as a Functional Carrier for the Local Delivery Anti-Inflammatory Systems Containing Extract.壳聚糖作为含提取物的局部递送抗炎系统的功能性载体。
Pharmaceutics. 2022 Oct 10;14(10):2148. doi: 10.3390/pharmaceutics14102148.
9
Progress in Research of Chitosan Chemical Modification Technologies and Their Applications.壳聚糖化学改性技术及其应用研究进展。
Mar Drugs. 2022 Aug 21;20(8):536. doi: 10.3390/md20080536.
10
The Chitosan-Based System with Extract for the Local Treatment of Vaginal Infections.含提取物的壳聚糖基系统用于阴道感染的局部治疗。
Pharmaceutics. 2022 Mar 29;14(4):740. doi: 10.3390/pharmaceutics14040740.
载有卡维地洛的脂纳米粒的研制,采用了相容的脂质,增强了在不同皮肤模型中的皮肤渗透。
J Microencapsul. 2021 Mar;38(2):124-133. doi: 10.1080/02652048.2020.1857862. Epub 2020 Dec 17.
4
The Application of Mucoadhesive Chitosan Nanoparticles in Nasal Drug Delivery.壳聚糖纳米粒在鼻腔给药中的应用。
Mar Drugs. 2020 Nov 29;18(12):605. doi: 10.3390/md18120605.
5
Hydroxypropyl-β-cyclodextrin as an effective carrier of curcumin - piperine nutraceutical system with improved enzyme inhibition properties.羟丙基-β-环糊精作为姜黄素-胡椒碱营养保健品系统的有效载体,具有改善的酶抑制特性。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):1811-1821. doi: 10.1080/14756366.2020.1801670.
6
Mucoadhesive Chitosan Delivery System with Lyophilized Extract as a Promising Strategy for Vaginitis Treatment.以冻干提取物为载体的粘膜粘附壳聚糖递送系统作为治疗阴道炎的一种有前景的策略。
J Clin Med. 2020 Apr 22;9(4):1208. doi: 10.3390/jcm9041208.
7
Oral formulation strategies to improve the bioavailability and mitigate the food effect of abiraterone acetate.口服制剂策略提高醋酸阿比特龙的生物利用度并减轻食物影响。
Int J Pharm. 2020 Mar 15;577:119069. doi: 10.1016/j.ijpharm.2020.119069. Epub 2020 Jan 22.
8
Role of Beta-blockers in Cardiovascular Disease in 2019.2019年β受体阻滞剂在心血管疾病中的作用
Rev Esp Cardiol (Engl Ed). 2019 Oct;72(10):844-852. doi: 10.1016/j.rec.2019.04.014. Epub 2019 Aug 8.
9
β-blockers in the treatment of periocular infantile hemangioma.β受体阻滞剂治疗眼周婴儿血管瘤。
Curr Opin Ophthalmol. 2019 Sep;30(5):319-325. doi: 10.1097/ICU.0000000000000591.
10
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting.基于壳聚糖纳米颗粒的药物递送与靶向的当前进展
Adv Pharm Bull. 2019 Jun;9(2):195-204. doi: 10.15171/apb.2019.023. Epub 2019 Jun 1.